Skip to main content

Decoding Immune Heterogeneity: Therapeutic Responses and Resistance in Diverse Cellular Landscapes

Cover image for Research Topic "Decoding Immune Heterogeneity: Therapeutic Responses and Resistance in Diverse Cellular Landscapes"
62kviews
Editorial08 July 2026
Editorial: Decoding immune heterogeneity: therapeutic responses and resistance in diverse cellular landscapes
Jianzhi Wang, Peiliang Xie, Manting Wang and Dawei Chen

Why can the same intervention help one patient, fail in another, or cause harm? Single-cell and multiomics studies have made this old pharmacological question more precise (1). Cells assigned to the same immune lineage may differ substantially in function because of their tissue location, differentiation history, metabolic state, treatment exposure, or disease stage (2). Methods that resolve and integrate these states have made molecularly informed patient selection more plausible. They have also shown how much biological variation can sit behind a single clinical diagnosis (3,4) .The Research Topic "Decoding Immune Heterogeneity: Therapeutic Responses and Resistance in Diverse Cellular Landscapes" follows this problem across inflammatory disease, cancer, neuroimmune injury, biomaterial-associated immune responses, and drug safety. Its contributions range from mechanistic experiments and single-cell analyses to prognostic modeling and pharmacovigilance. The methods are diverse because the underlying question appears at several scales: cellular state, local tissue organization, patient variation, and treatment exposure.Our aim here is to read these papers together. The clearest links arise where a biological difference is connected to an intervention and an observable result, such as treatment benefit, resistance, tissue repair, or an adverse-event signal. The limits are just as informative. A molecular association may suggest a mechanism without establishing one, and a predictive model may perform well in its development dataset without being ready for clinical use.

Inflammatory diagnoses remain clinically necessary, but they can group together patients whose disease is sustained by different immune processes (5). Across this part of the collection, T cell differentiation, local metabolism, non-coding RNA regulation, and neuroimmune signaling are considered as possible sources of that variation. The articles are therefore linked less by organ system than by the question of which process is actually driving inflammation in a given setting.

1,606 views

ORIGINAL RESEARCH
7 September 2026
Immune heterogeneity-driven therapeutic responses to platelet-rich plasma and TRPV1 antagonism in osteoarthritis
Pengmin Liu, 4 more and Laifu Yang

1,391 views

ORIGINAL RESEARCH
24 June 2026
Single-cell dissection and multi-cohort validation identify a hypoxia-related prognostic signature with experimental verification in lung adenocarcinoma
Fan Zhang, 4 more and Chengyuan Liu

1,039 views

ORIGINAL RESEARCH
2 June 2026
Decoding neuroimmune ferroptotic vulnerability in isoflurane-induced neonatal neurotoxicity via the SLC7A11/GPX4 axis
Pingping Huang, 2 more and Lijun Xue

1,411 views

REVIEW
22 April 2026
Molecular mechanisms underlying T cell subset imbalance and precision therapeutic targets in primary biliary cholangitis
Bukun Zhu, 6 more and Wei Zhang

2,485 views

1 citations

ORIGINAL RESEARCH
23 March 2026
Integrative single-cell analysis reveals immunogenic cell death–associated heterogeneity and identifies a robust prognostic signature in osteosarcoma with experimental validation
Zhaochen Xu, 4 more and Weiguo Bian

1,999 views

ORIGINAL RESEARCH
1 April 2026
Mesenchymal stem cells promote cisplatin resistance in non-small cell lung cancer through IL-6/MEK-ERK/macrophages axis: construction of prognostic signature and experimental investigation
Xinchun Ma, 8 more and Yanguo Liu

1,688 views

ORIGINAL RESEARCH
1 May 2026
Long non-coding RNA AC245100.4 for early diagnosis and prognostic assessment in acute pancreatitis: clinical value and inflammation-regulatory mechanisms
Jie Chen, 1 more and Peng Yi

1,468 views

REVIEW
15 January 2026
Glutathione and neurodegenerative diseases: immunopharmacological implications
Ethan Knudsen, 2 more and Vishwanath Venketaraman

6,436 views

21 citations

ORIGINAL RESEARCH
25 February 2026
A thermosensitive hydrogel encapsulating 2-DG alleviates periodontitis by inhibiting glycolysis and effector response of Th17 cells
Ruowen Zhao, 7 more and Junhua Wu

1,380 views

3 citations

ORIGINAL RESEARCH
12 January 2026
Partially hydrolyzed formula with high sn-2 palmitic acid on eosinophils and outcomes in preterm infants: PRIOR secondary analysis
Jialu Zhuang, 14 more and Li Hong

1,961 views

ORIGINAL RESEARCH
3 October 2025
Decoding monocyte heterogeneity in sepsis: a single-cell apoptotic signature for immune stratification and guiding precision therapy
Wenjuan Duan, 4 more and Yan Zhang

5,349 views

6 citations

REVIEW
10 November 2025
Decoding the heterogeneity of liver-resident macrophages in chronic liver diseases: therapeutic responses to immunomodulatory strategies
Renbin Ouyang, 7 more and Yu Sun

3,713 views

5 citations